HUTCHMED (China) Ltd Files Routine 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Dec 3, 2024 · CIK: 1648257
| Field | Detail |
|---|---|
| Company | Hutchmed (China) LTD (HMDCF) |
| Form Type | 6-K |
| Filed Date | Dec 3, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
HUTCHMED (China) Ltd filed a standard 6-K, no major news.
AI Summary
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 3, 2024. This filing is a report of a foreign private issuer and does not contain specific financial or operational updates beyond its routine nature. The company is incorporated in E9 and its principal executive offices are located in Hong Kong.
Why It Matters
This filing indicates routine corporate reporting for HUTCHMED (China) Limited as a foreign private issuer, providing transparency to investors about its ongoing compliance with SEC regulations.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain any new material information that would significantly alter the risk profile of the company.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Filer
- Hutchison China MediTech Ltd (company) — Former company name
- 20241203 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to provide information that the company makes or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on December 3, 2024.
What is the principal executive office address for HUTCHMED (China) Limited?
The principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?
HUTCHMED (China) Limited indicates it files annual reports under cover of Form 20-F.
What was the former name of HUTCHMED (China) Limited?
The former name of HUTCHMED (China) Limited was Hutchison China MediTech Ltd, with a date of name change on July 16, 2015.
Filing Stats: 180 words · 1 min read · ~1 pages · Grade level 14.8 · Accepted 2024-12-03 06:04:33
Filing Documents
- hcm-20241203x6k.htm (6-K) — 21KB
- hcm-20241203xex99d1.htm (EX-99.1) — 50KB
- hcm-20241203xex99d1001.gif (GRAPHIC) — 4KB
- hcm-20241203xex99d1002.jpg (GRAPHIC) — 8KB
- 0001648257-24-000092.txt ( ) — 88KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED and Innovent jointly announce NMPA conditional approval for ELUNATE (Fruquintinib) in combination with TYVYT (Sintilimab Injection) for the treatment of advanced endometrial cancer 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: December 3, 2024 3